<List><item><source>MED</source><extId>29436901</extId><pmcid>PMC5973687</pmcid><annotations><annotation><prefix>cture of TL1A (PDB: </prefix><exact>2RE9</exact><postfix>) showing ARG32 (R32</postfix><tags><tag><name>2RE9</name><uri>http://identifiers.org/pdb/2RE9</uri></tag></tags><id>http://europepmc.org/articles/PMC5973687#europepmc-f1872f4bbb863f4169f77c5280715917</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>identified from PDB:</prefix><exact>2RE9</exact><postfix> were generated by g</postfix><tags><tag><name>2RE9</name><uri>http://identifiers.org/pdb/2RE9</uri></tag></tags><id>http://europepmc.org/articles/PMC5973687#europepmc-e18ff009dff5e7d8a7ceef65e8c657f2</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix> is the subject of a clinical trial (</prefix><exact>NCT01989143</exact><postfix>). </postfix><tags><tag><name>NCT01989143</name><uri>http://identifiers.org/clinicaltrials/NCT01989143</uri></tag></tags><id>http://europepmc.org/articles/PMC5973687#europepmc-9513941fe3521985847b97ebc21a1509</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>